Clinical Research Papers:
Clinicopathological characteristics and survival outcomes in adenosquamous carcinoma of the lung: a population-based study from the SEER database
PDF | HTML | Supplementary Files | How to cite
Metrics: PDF 2230 views | HTML 2539 views | ?
Abstract
Jian Wang1,*, Bi Lian2,*, Ling Ye1,*, Jie Hu1 and Yuanlin Song1
1Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai 200030, China
2Department of Breast Surgery, Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, Fudan University, Shanghai 200030, China
*These authors contributed equally to this work
Correspondence to:
Yuanlin Song, email: [email protected]
Jie Hu, email: [email protected]
Keywords: adenosquamous carcinoma; adenocarcinoma; squamous cell carcinoma; prognosis
Received: September 07, 2017 Accepted: October 28, 2017 Published: December 21, 2017
ABSTRACT
Adenosquamous carcinoma (ASC) of the lung is an unusual histology type in non-small-cell lung cancers. Due to its rarity, the clinicopathological characteristics and survival outcomes of the lung ASC are incompletely understood. We used the Surveillance, Epidemiology, and End Results (SEER) database to enroll 203,208 eligible patients, including 4,245 ASC, 124,253 adenocarcinoma (ADC) and 74,710 squamous cell carcinoma (SCC) patients. To date, this is the largest cohort in a study for ASC of the lung. With regard to age, sex, race, year of diagnosis, tumor size and SEER stage, ASC was intermediate between ADC and SCC. However, compared with ADC and SCC patients, ASC patients presented with a higher tumor grade and lower prevalence of nodal metastasis. More ASC patients underwent surgery and a lower proportion underwent radiation treatment and chemotherapy. Kaplan-Meier analysis showed that ASC patients had a better prognosis than ADC and SCC patients, but stratified analysis showed that the prognosis of ASC patients was worse than that of ADC and SCC patients in surgery and non-surgery subgroup. Multivariate analysis further confirmed that the ASC histology type was a risk factor for poor prognosis with respect to ADC and SCC. Using the propensity score matching to 1:1 match ASC with ADC or SCC, we found that ASC patients had worse survival than ADC and SCC patients. Subgroup analysis further demonstrated that ASC was a more aggressive histology type with a worse prognosis. These results provided a deep understanding of ASC, which contributed to better clinical diagnosis and treatment.
![Creative Commons License](/images/80x15.png)
PII: 23550